Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 6, 2013 - Issue
Submit an article Journal homepage
124
Views
6
CrossRef citations to date
0
Altmetric
Review

Non-small-cell lung cancer: molecular targeted therapy and personalized medicine – drug resistance, mechanisms, and strategies

Marybeth Sechler1 Division of Pulmonary Sciences and Critical Care, University of Colorado, Aurora, CO, USA;2 Program in Cancer Biology, University of Colorado, Aurora, CO, USA
,
Amber D Cizmic3 Veterans Affairs Medical Center, Denver, CO, USA
,
Sreedevi Avasarala1 Division of Pulmonary Sciences and Critical Care, University of Colorado, Aurora, CO, USA
,
Michelle Van Scoyk1 Division of Pulmonary Sciences and Critical Care, University of Colorado, Aurora, CO, USA
,
Christine Brzezinski1 Division of Pulmonary Sciences and Critical Care, University of Colorado, Aurora, CO, USA
,
Nicole Kelley1 Division of Pulmonary Sciences and Critical Care, University of Colorado, Aurora, CO, USA
,
Rama Kamesh Bikkavilli1 Division of Pulmonary Sciences and Critical Care, University of Colorado, Aurora, CO, USA
&
Robert A Winn1 Division of Pulmonary Sciences and Critical Care, University of Colorado, Aurora, CO, USA;2 Program in Cancer Biology, University of Colorado, Aurora, CO, USA;3 Veterans Affairs Medical Center, Denver, CO, USACorrespondence[email protected]
 show all
Pages 25-36 | Published online: 04 Apr 2013

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mufassir Mushtaque Momin, Zahid Zaheer, Rana Zainuddin & Jaiprakash N. Sangshetti. (2018) Extended release delivery of erlotinib glutathione nanosponge for targeting lung cancer. Artificial Cells, Nanomedicine, and Biotechnology 46:5, pages 1064-1075.
Read now
Ruixue Qi, Tiankui Qiao & Xibing Zhuang. (2016) Small interfering RNA targeting S100A4 sensitizes non-small-cell lung cancer cells (A549) to radiation treatment. OncoTargets and Therapy 9, pages 3753-3762.
Read now

Articles from other publishers (4)

Cong Wang, Fang Chen, Yichen Liu, Qingqing Xu, Liang Guo, Xiaoqing Zhang, Yunfeng Ruan, Ye Shi, Lu Shen, Mo Li, Huihui Du, Xiaofang Sun, Jingsong Ma, Lin He & Shengying Qin. (2018) Genetic Association of Drug Response to Erlotinib in Chinese Advanced Non-small Cell Lung Cancer Patients. Frontiers in Pharmacology 9.
Crossref
Mojca Humar, Izidor Kern, Gregor Vlacic, Vedran Hadzic & Tanja Cufer. (2017) Insulin-like growth factor 1 receptor expression in advanced non-small-cell lung cancer and its impact on overall survival. Radiology and Oncology 51:2, pages 195-202.
Crossref
Dipanwita Das Mukherjee, N. Maruthi Kumar, Mukund P. Tantak, Amlan Das, Arnab Ganguli, Satabdi Datta, Dalip Kumar & Gopal Chakrabarti. (2016) Development of Novel Bis(indolyl)-hydrazide–Hydrazone Derivatives as Potent Microtubule-Targeting Cytotoxic Agents against A549 Lung Cancer Cells. Biochemistry 55:21, pages 3020-3035.
Crossref
Johanna N. Spaans & Glenwood D. Goss. (2014) Drug Resistance to Molecular Targeted Therapy and Its Consequences for Treatment Decisions in Non-Small-Cell Lung Cancer. Frontiers in Oncology 4.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.